Foresite Capital Management VI »

Onkure Therapeutics Inc-a shares owned by Foresite Capital Management VI

Quarter-by-quarter ownership of Onkure Therapeutics Inc-a (OKUR) shares owned by Foresite Capital Management VI from 13F filings

Historical chart of Foresite Capital Management VI investment in Onkure Therapeutics Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Onkure Therapeutics Inc-a held by Foresite Capital Management VI consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Onkure Therapeutics Inc-a by Foresite Capital Management VI

Quarter filed Position value Share count Share price at filing
2026-03-31 $6.0M 1.4M 4.14

More positions owned by Foresite Capital Management VI

Cg Oncology (CGON)
Alumis (ALMS)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Corvus Pharmaceuticals (CRVS)
Denali Therapeutics (DNLI)
Agios Pharmaceuticals (AGIO)
Verastem (VSTM)
Kymera Therapeutics (KYMR)
Minerva Neurosciences (NERV)
Celldex Therapeutics (CLDX)
Ataibeckley (ATAI)
Hinge Health Cl A (HNGE)
Crinetics Pharmaceuticals In (CRNX)
OnKure Therapeutics Com Cl A (OKUR)
Jade Biosciences (JBIO)

View all positions for Foresite Capital Management VI

Top funds holding Onkure Therapeutics Inc-a

RA Capital Management
Acorn Capital Advisors
StepStone
ADAR1 Capital Management
BVF
Vivo Capital
Vestal Point Capital
Foresite Capital Management VI
Prosight Management
Rosalind Advisors
Vanguard Group
Vanguard Capital Management
Highbridge Capital Management
NEA Management Company
Carlyle

View all funds holding Onkure Therapeutics Inc-a